Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, indicating a minor page revision.
    Difference
    0.0%
    Check dated 2026-04-30T16:40:47.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2; the prior revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:34:35.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:16:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:25:59.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Gastric cancer is added as a related topic and the Genetic and Rare Diseases Information Center is added as a resources entry for gastric cancer.
    Difference
    0.1%
    Check dated 2026-02-18T07:29:07.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a new site revision label: Revision: v3.4.2. The government funding lapse notice and the earlier Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:37:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.